ACAM2000 smallpox
Selected indexed studies
- ACAM2000® Smallpox Vaccine. (, 1994) [PMID:36037535]
- Pathological skin manifestations following smallpox vaccination (ACAM2000) in US military personnel, 2009-2023: a systematic review. (Proc (Bayl Univ Med Cent), 2024) [PMID:39165802]
- ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. (Expert Opin Investig Drugs, 2008) [PMID:18363519]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Mpox: Global epidemic situation and countermeasures. (2025) pubmed
- ACAM2000® Smallpox Vaccine. (1994) pubmed
- Pathological skin manifestations following smallpox vaccination (ACAM2000) in US military personnel, 2009-2023: a systematic review. (2024) pubmed
- ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. (2008) pubmed
- ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. (2010) pubmed
- Smallpox Vaccine. (2006) pubmed
- Safety and Efficacy of Repurposed Smallpox Vaccines Against Mpox: A Critical Review of ACAM2000, JYNNEOS, and LC16. (2025) pubmed
- Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel. (2020) pubmed
- Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members. (2021) pubmed
- Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®). (2013) pubmed